Medicare expands coverage for genetic counseling services starting 2027

What it does

This bill expands Medicare coverage to include genetic counseling services furnished by licensed or certified genetic counselors, effective January 1, 2027. Medicare will pay 80% of the lesser of actual charges or 85% of the physician fee-schedule equivalent, and genetic counselors will be subject to balance-billing restrictions. The bill does not prevent physicians or other providers from continuing to bill for genetic counseling services they already cover.

Why we flagged it

The bill's operative mechanism is straightforward: it adds a new covered service category to Medicare Part B, defines the provider type, sets payment rates, and establishes balance-billing protections. This is routine healthcare coverage legislation, not a tax provision, deregulation, or subsidy carve-out.

What the text implies

• Payment is pegged to 85% of the physician fee schedule, not a standalone genetic counselor fee schedule—this may create payment pressure if genetic counselor services are typically less resource-intensive than physician services, potentially affecting counselor compensation and market entry.
• The bill permits physicians and other providers to continue billing for genetic counseling under existing coverage rules, creating potential for dual billing pathways and inconsistent payment rates depending on provider type—may incentivize physician billing over genetic counselor billing.
• Implementation via interim final rule (with comment period) compresses the rulemaking timeline and may limit stakeholder input on payment rates, coding, and qualification standards before the January 1, 2027 effective date.
• State licensure requirement creates a patchwork: states without genetic counselor licensure laws must rely on American Board of Genetic Counseling certification, potentially excluding qualified counselors in non-licensing states or creating barriers to interstate practice.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Seniors and disabled Medicare beneficiaries gain direct access to a specialized preventive and diagnostic service (genetic counseling) with defined cost-sharing (20% coinsurance) and balance-billing protections. The service addresses a genuine clinical need and expands choice without restricting existing coverage or raising premiums.

Who stands to gain

• genetic counselors and genetic counseling practices
• healthcare systems and clinics employing genetic counselors
• diagnostic laboratories and genomic testing providers (indirect, via increased counseling referrals)

Named in the bill

Medicare (Centers for Medicare & Medicaid Services), genetic counselors, American Board of Genetic Counseling, physicians, health care providers, state regulatory bodies

Where it stands

37 cosponsors: 28 Democrats, 9 Republicans.

• Nov 21, 2025 — Introduced · Congress.gov: “Introduced in House”
• Nov 21, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

12 lobbying clients named this bill on 15 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $10,393,000 in lobbying spend. A filing names 14 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 93% of bills with at least one filing.

Adrian Smith, the sponsor, reported $1,398,750 in PAC receipts in the 2026 cycle.

• American Medical Association — $5,643,000 on 2 filings
• American Cancer Society Cancer Action Network Inc — $3,620,000 on 2 filings
• Laboratory Corporation of America Holdings — $250,000 on 1 filing
• American Kidney Fund — $240,000 on 1 filing
• The Susan G. Komen Breast Cancer Foundation, Inc. Dba Susan G. Komen — $130,000 on 1 filing

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.